21 results on '"Pirker, R."'
Search Results
2. 9000 ORAL Epidermal Growth Factor Receptor (EGFR) Expression as a Predictive Biomarker of Survival in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving First-Line Therapy With Cetuximab Combined With Chemotherapy in the FLEX Trial
3. 9019 POSTER DISCUSSION Safety Analysis of Patient Subgroups Defined by Low and High Tumour Epidermal Growth Factor Receptor (EGFR) Expression in FLEX Study Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Chemotherapy With or Without Cetuximab as First-Line Therapy
4. A phase III, double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer
5. Randomized Pan-European trial comparing paclitaxel (TAX)/carboplatin (CAR) versus paclitaxel/cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC)
6. Extensive clinical experience with Taxotere® (T) in 1st and 2nd line treatment at 100 mg/m2 in locally advanced or metastatic NSCLC
7. Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial
8. Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
9. Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy
10. MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas
11. 92 P - MRP and MDR1 Gene expression in primary breast carcinomas
12. 26 P - Monitoring of neurotoxicity of taxanes
13. 43 P - Paclitaxel/cisplatin in stage IIIB/IV non-small-cell lung cancer
14. 150 P - Expression of the drug resistance genes MDR1, MRP, GSTπ and MT2A in human primary gastric carcinomas
15. 132 MRP gene expression in colorectal carcinomas
16. MDRl gene expression in acute myeloid leukemia
17. MDR1 RNA Transcripts do not Indicate Long-term Prognosis in Colorectal Carcinomas
18. Extensive clinical experience with Taxotere® (T) in 1st and 2nd line treatment at 100 mg/m 2 in locally advanced or metastatic NSCLC
19. 150 P - Expression of the drug resistance genes MDR1, MRP, GSTπ and MT2A in human primary gastric carcinomas
20. 1139 - Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
21. 150 P - Expression of the drug resistance genes MDR1, MRP, GSTπ and MT2 A in human primary gastric carcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.